Data are available at <http://figshare.com/articles/Dataset_pone/1437749>.

Introduction {#sec001}
============

Noise exposure is a primary cause of hearing loss with a broad range of secondary non-auditory effects including cognitive impairment, sleep disturbance and cardiovascular disease \[[@pone.0130827.ref001]\]. Noise-induced hearing loss (NIHL), which correlates highly with tinnitus, is the most common and significant occupational health issue, affecting 16% of the population worldwide \[[@pone.0130827.ref002]\].

In the inner ear, noise exposure affects the lateral wall, organ of Corti and afferent neurons resulting in hearing impairment categorized as either temporary or permanent hearing threshold shifts. Although there are morphological and functional differences associated with either form of hearing impairment, the molecular basis for that difference is not well defined. However, it is well established that the permanence of hearing loss resides principally in the irreversible loss of cochlear hair cells in the organ of Corti \[[@pone.0130827.ref003], [@pone.0130827.ref004], [@pone.0130827.ref005]\], with some contribution of the stria vascularis \[[@pone.0130827.ref006]\] and afferent neurons \[[@pone.0130827.ref007]\]. Numerous reports suggest oxidative stress resulting from increased levels of reactive oxygen species after noise exposure is the predominant contributing mechanism to the loss of these hair cells \[[@pone.0130827.ref005], [@pone.0130827.ref008]\]. This increase in reactive oxygen species damages mitochondria, triggering the release of pro-apoptotic factors that activate a cellular apoptotic response \[[@pone.0130827.ref005], [@pone.0130827.ref008]\]. Loss of hair cells by apoptosis following noise exposure may also result from extracellular potassium dysregulation through alteration of cell-cell junctions between hair cells and Hensen\'s cells in the organ of Corti \[[@pone.0130827.ref003], [@pone.0130827.ref008], [@pone.0130827.ref009]\].

Supporting the role of oxidative stress and apoptosis in hearing loss, administration of antioxidants in animal models exposed to noise and inhibition of apoptotic signaling pathways, respectively, have shown efficacy in preventing cochlear hair cell loss \[[@pone.0130827.ref010]--[@pone.0130827.ref012]\] and is bio-available through several routes to the cochlea \[[@pone.0130827.ref013]\].

The susceptibility of individuals to NIHL results from both environmental factors that increase physiological stress, inflammation and oxidative stress \[[@pone.0130827.ref003], [@pone.0130827.ref006], [@pone.0130827.ref014]\]; and from genetic factors \[[@pone.0130827.ref015]\]. Genomic studies utilizing candidate gene analyses or genome-wide association studies (GWAS) have identified some of the genetic variants associated with NIHL susceptibility \[[@pone.0130827.ref015]\]. Coincidental with the known mechanisms of hearing loss, these studies have reported polymorphisms in oxidative stress response pathways, involving HSP70 and SOD1 proteins; as well as potassium recycling pathways, involving KCNQ4 and KCNE2 proteins \[[@pone.0130827.ref015]\].

Here, we report the results of a GWAS identifying a novel susceptibility locus associated with NIHL in 41 individuals selected amongst 314 age-controlled subjects during their first encounter with occupational noise. We then validate the potential role of nucleolin, the top candidate gene containing a significant SNP in our study, by developing a HEI-OC1 cochlear cell with silenced nucleolin, then experimentally testing its susceptibility to oxidative stress conditions and to ototoxic drug cisplatin.

Materials and Methods {#sec002}
=====================

Ethics Statement {#sec003}
----------------

The protocol for the collection of saliva samples and the identification of biomarkers of susceptibility to NIHL by GWAS was reviewed and approved by the Institutional Review Board at Naval Medical Center, San Diego. The use of de-identified saliva samples for DNA analysis was further reviewed by the Institutional Review Board at Harvard and received a non-human subject approval. All volunteers enrolled in the study provided written informed consent for saliva collection and its use for the identification of genetic markers. Samples were de-identified, anonymized and an identification number was randomly assigned to each subject. At the time of the saliva collection, samples were labeled with the randomized identification number used throughout the analysis.

Subject Selection Criteria for Inclusion in the Marine Recruit Study {#sec004}
--------------------------------------------------------------------

Subjects were randomly selected from a pool of volunteer participants enrolled in the placebo arm of the Marine Recruit Study "*Prevention of Noise-Induced Hearing Loss Using the Antioxidant Supplement*, *N-acetylcysteine*: *Impulse Noise Study* (*NMCSD*.*2007*.*0013*)". Briefly, subjects were in good health as determined by enlistment criteria, without previous exposure to military noise. For admission into the study, subjects were required to have normal hearing in both ears (no hearing threshold greater than 25 dB HL (Hearing Level) at any of the 1, 2, 3, 4, 6 kHz standard audiometric test frequencies and no more than 30 dB SPL (Sound Pressure Level) asymmetry between ears at 8 kHz). Subjects were required to have normal tympanometry on baseline and on the day of final hearing testing, 5 weeks after pre-exposure audiogram. Recruits with abnormal tympanograms consistent with middle ear pathology and those with prior history of head trauma were excluded. The average age of the study participants was 19.82 years old.

Noise Exposure {#sec005}
--------------

During their training period, subjects underwent 10 days of small arms training with an M16 rifle, which commonly generates an approximate 157 dB peak SPL impulse noise \[[@pone.0130827.ref016]\]. More precisely, noise exposure was spread over a period of 16 days in 2 series of 5 days with a period of 6 days in-between. The bulk of the firing occurred during the first 5 days of the 16 days period. Each subject fired up to 325 rounds of ammunition and was monitored for their use of hearing protective devices, consisting of foam ear-plugs in accordance with standard operating procedures. Standard military foam ear plugs used had a NRR of 29 dB (Noise Reduction Rating) with expected attenuation of 22 dBA as per OSHA standard.

Audiogram Collection {#sec006}
--------------------

Subjects underwent pre-exposure audiograms 6 to 7 days prior to noise exposure. A post-exposure audiogram was administered 12 days after last noise exposure which took place 36 to 37 days after the pre-noise exposure audiogram. At the time of the post-exposure audiograms, every threshold shift greater than 5 dB HL compare to pre-exposure audiogram was checked twice. Subjects with a hearing change also underwent a final tympanogram to rule out middle ear pathology as a cause of the hearing loss. Audiograms were performed by certified audiologists on clinical audiometer Interacoustics AC40 (Minneapolis, MN/USA) with a 5 dB step size sound level, and using TDH-39P earphones for 500 Hz and 1, 2, 3, 4, 6 kHz and Koss Pro/KTX-6 earphones (Milwaukee, WI/USA) for 8 kHz. Earphones were calibrated daily using OSCAR electro-acoustic ear simulators (Tremetrics, Eden Prairie, MN/USA) and data were collected in double-walled sound-attenuated booths (Acoustics Systems, Austin, TX/USA).

Selection Criteria for GWAS Analysis {#sec007}
------------------------------------

In the study reported here, only the Marine recruits from the control arm (placebo) of the retrospective impulse noise study (NMCSD.2007.0013) were included. Subjects were divided in hearing loss versus no hearing loss groups by calculating the mean threshold shift per subject. Briefly, the threshold shifts between post- and pre-exposure audiograms were first calculated for each ear at 2, 3 and 4 kHz frequencies respectively (n = 6 data points per individual) and then averaged for each subject. The mean threshold shift provides a unified single parameter that best captures all combinations by which hearing threshold may change, and is associated with conversational frequencies most relevant to future impact on the ability to hear the spoken word. Subjects were considered to have hearing loss if the mean threshold shift between pre- and post-exposure of both ears at frequencies 2, 3 and 4 kHz was greater than zero. In contrast, subjects had no hearing loss if the mean threshold shift of both ears at frequencies 2, 3 and 4 kHz was less or equal to 0. For this study, a total of 48 samples were included, consisting of 23 samples randomly selected from a pool of 204 subjects who sustained no hearing loss and 25 samples randomly selected from a pool of 110 subjects who sustained hearing loss. None of the selected samples presented more than 20 dB SPL asymmetry between ears at 8 kHz for either pre- or post-exposure audiograms.

Genotyping and Quality Controls {#sec008}
-------------------------------

The DNA isolated from the de-identified saliva samples collected at the time of the post-exposure audiogram was genotyped at Boston University Microarray Core Resource facility on Genome-Wide Human SNP Array 6.0 (Affymetrix, Santa Clara, CA).

Quality controls of the genotyped DNA were performed following GWAS standards \[[@pone.0130827.ref017]\]. Samples or SNPs failing these controls were removed from further analysis. From the genotype call using Birdsuite 1.5.5 \[[@pone.0130827.ref018]\], five samples were removed due to high variance estimate. For SNPs quality control, SNPs with a minor allele frequency \< 5%, a genotyping call rate per SNP \< 99%, or in Hardy-Weinberg disequilibrium (p \< 10^−5^) were removed. Individuals with missingness \> 1.5% were also removed. The genetic gender was checked with PLINK \[[@pone.0130827.ref019]\] and all matched to the gender reported in the phenotype file for all samples.

Samples were tested for duplicates and relatedness between subjects. For this a subset of autosomal SNPs in approximate linkage equilibrium were selected in PLINK to determine pairwise Identity-By-Descent (IBD). Autosomal SNPs with a genotyping call rate per SNP \> 0.999, minor allele frequency \> 5%, and a 100% call rate per sample were pruned to be on linkage equilibrium using the default settings of PLINK, resulting in a pruned set of 31,362 SNPs per sample to test for duplicates and relatedness. Pi-hat values showed there was no duplicate sample (all pi-hat \< 0.9) and only one pair of individuals showed relatedness (pi-hat \> 0.185). The individual with the lowest genotyping rate of the related pair was removed.

The population structure was assessed by principal component analysis using SNPRelate \[[@pone.0130827.ref020]\] in R version 3.0.2 \[[@pone.0130827.ref021]\]. For this, the founder population of Hapmap phase 3 release 2 (988 individuals) \[[@pone.0130827.ref022]\] and the NIHL study population were merged with PLINK. SNPs with A/T and C/G variants were removed to prevent allele swap mismatch and only SNPs common to all datasets were used. SNPs were flipped to match with sense of the strand. From the principal component analysis on the merged population, principal components 1 and 2 were used to identify and remove population outliers from the sample and adjust for population stratification to prevent bias. Only one sample fell outside the reference clusters and was subsequently removed.

As a final quality control measure, we used quantile-quantile plot and the genomic inflation score λ \< 1.00. In total, 41 samples out of the 48 genotyped samples passed the quality controls.

Reagents for In Vitro Studies {#sec009}
-----------------------------

The cochlear hair cell line HEI-OC1 \[[@pone.0130827.ref023]\] was a generous gift of Dr. Kalinec (House Ear Institute, Los Angeles, CA, USA). High-glucose Dulbecco\'s Modified Essential Medium (DMEM, cat no. 11965--092) and fetal bovine serum (cat no. 26140--111) were purchased from Life Technologies. Cisplatin (cat no. 479306) and Mission shRNA containing lentiviral particles were purchased from Sigma-Aldrich. ATPlite one step assay (cat no. 6016731) was purchased from Perkin Elmer and CellTox Green Cytotoxicity Assay (cat no. G8741) from Promega.

Cell Culture and Silencing of Nucleolin {#sec010}
---------------------------------------

For propagation, HEI-OC1 cells were cultured in high-glucose DMEM with 10% FBS at the permissive temperature of 33°C and 5% CO~2~. All experiments were performed on cells transferred to the non-permissive temperature of 39°C, 5% CO~2~.

To determine the effect of nucleolin down-regulation on HEI-OC1 cells, we constructed stable clones expressing shRNA targeted against nucleolin. For this, lentiviral particles containing either shRNA directed against nucleolin or a scramble shRNA for control were transfected at the permissive temperature of 33°C following a modified version of the protocol provided by the manufacturer. Briefly, on day 1, cells were seeded in 96 well plates at 5,000 cells / well in 110 μL of media containing 8 μg/mL of Hexadimethrine Bromide (Sigma) and the equivalent of 1 MOI (multiplicity of infection) of lentiviral particles. On day 2, the media containing the lentiviral particles was removed and replaced with fresh media. On day 3, the media was replaced with media containing 8 μg/mL of puromycin, which was then replaced every 3 days. At 90% confluence, cells were detached using trypsin EDTA (0.25%) solution with phenol red (Life Technologies, cat. no. 25200056) and cultured on 10 cm tissue culture Petri dishes for colony selection and expansion. Nucleolin silencing was confirmed by qPCR and Western Blot. A HEI-OC1 nucleolin-silenced clone, labeled sh-Ncl, with greater than 50% silencing, as confirmed by RTqPCR and Western Blot, was chosen for the viability and cytotoxicity experiments. Cells from the scramble transfection, labeled sh-Scr, were used as control.

RTqPCR {#sec011}
------

To assess silencing of the nucleolin gene, RNA was extracted using the RNeasy minikit from Qiagen and the Qiacube for semi-automated column processing, utilizing Qiashredder (Qiagen) for cell lysis and on-column DNA digestion (RNase free DNase Set, Qiagen). Extracted RNA was quantified using Take-3 plate from Biotek and Biotek's Synergy H1 multiplate reader. 40 ng of RNA were used for a 20 μL reverse transcription reaction using SuperScript III enzyme from Invitrogen, following the manufacturer's protocol. The qPCR was done using the LC96 equipment and FastStart Universal SYBR Green PCR Master Mix from Roche. 10 μL reactions were done with 5 μL of a 1:10 cDNA dilution, following the recommendation of the manufacturer and an annealing temperature of 59°C. Primer pairs for nucleolin and reference gene β-actin were: Nucleolin Forward: 5'-CAGAACCCACATGGCAAACC-3'; Nucleolin Reverse: 5'-GCCTGATTGTTCTGCCCTCA-3'; β-actin Forward: 5'-ATGTGGATCAGCAAGCAGGA-3'; β-actin Reverse: 5'-AAGGGTGTAAAACGCAGCTC-3'.

Western Blot {#sec012}
------------

To assess silencing of nucleolin protein, cells at 80% confluence were lysed directly on the plate using NP-40 lysis buffer (10% Glycerol, 1% NP-40, 1mM MgCl2, 20 mM Tris-HCLpH4, 150 mM NaCl, and 50 mM B-glycerophosphate in water) supplemented with protease and phosphatase inhibitor cocktail (Thermo Scientific, Cat. No. 78420 and Sigma Aldrich, Cat. No. P8340, respectively) for 15 min on ice. Protein concentration was determined via Bradford assay, and 15 μg of protein were prepared in loading buffer composed of Laemmli (Biorad 161--0737) and 2-Mercaptoethanol solution (Sigma M3148) prepared according to the manufacturer's instructions, boiled for 5 min and loaded into a 12% acrylamide gel. Electrophoresis and protein transfer using a PVDF membrane (Biorad 162--0177) was performed following the protocol provided by Abcam. Primary antibody (AB22758, Abcam) was diluted 1:1000 in blocking buffer and incubated overnight at 4°C and secondary antibody (AB7074, Cell Signaling) was diluted 1:5000 and incubated for 3 h. The blot was developed using Clarity Western ECL substrate (Bio-Rad 170--5060). Experiments were done in duplicate.

Viability and Cytotoxicity {#sec013}
--------------------------

Nucleolin silenced clone sh-Ncl and scramble clone sh-Scr were seeded in 96-well plates at a density of 8,000 cells / well in 100 μL of media and cultured overnight under permissive temperature conditions for a confluence of 50% to 60%. Thereafter, the cells were transferred to non-permissive temperature conditions. After overnight incubation, cells reached 80% to 90% confluence and were treated with cisplatin (50 μL of 20 μM cisplatin in culture media) for 6h, in non-permissive conditions. Cell membrane damage and ATP production were multiplexed in 96-well plates using CellTox Green Cytotoxicity Assay and ATPlite one step assay, following the respective manufacturer's instructions. The CellTox Green Cytotoxicity assay was performed first, followed by ATPlite assay. Briefly, a 1:500 dilution working stock of the CellTox Green dye was prepared in assay buffer and added in a 1:1 ratio to the wells at 100 μL per well. Plates were mixed at 700 rpm for 1 min in a microplate shaker and left to equilibrate at room temperature (RT) for 15 min. Fluorescence was measured using the Synergy H1 multiplate reader (Biotek), at an excitation/emission wavelengths of 485/528 nm respectively. 100 μL of volume were removed from each well and discarded. To perform the ATPlite one step assay, an equal volume of reconstituted reagent (100 μL) was added per well with plate mixed at 700 rpm for 2 min in a microplate shaker. Luminescence was then read using Synergy H1 multiplate reader. The assay was performed in duplicate with n = 4.

Immunocytochemistry and Confocal Microscopy {#sec014}
-------------------------------------------

To evaluate the altered expression of nucleolin protein in sh-Ncl clones, we undertook immunocytochemical staining of nucleolin in cells in culture. In normal cells, nucleolin is associated to the fibrillar components in nucleoli \[[@pone.0130827.ref024]\]. Immunocytochemistry labeling protocols were applied to cells seeded in Lab-Tek II 4-well chamber slides (Nalgen Nuc) \[[@pone.0130827.ref025]\]. After incubation, wells were washed from residual culture media with Dublecco's Phosphate Buffered Saline (DPBS) and Tris-Buffered Saline solution with 0.1% Tween 20 (TBS-T), then fixed in 4% paraformaldehyde in PBS pH 7.2, freshly diluted from 16% paraformaldehyde, for 10 min at RT. Cells were briefly washed in TBS-T then incubated for 10 min in permeabilizing buffer (0.2% saponin in TBS-T) rinsed in TBS-T. To reduce non-specific staining, cells were incubated for 1 h at RT with blocking solution (2% normal goat serum, 0.3% bovine serum albumin, 0.3 M glycine in TBS-T, filter sterilized). Blocking solution was removed and primary antibody, mouse anti-Nucleolin in Rabbit (AB22758), in a 1:100 dilution in blocking solution was added and incubated overnight at 4°C. Wells were washed 3 times with TBS-T for 15 min each wash and incubated for 1 h with secondary antibody Goat Anti-Rabbit IgG with Texas Red (AB6719, Abcam) and Alexa Fluor 488 phalloidin (A12379, Life Technologies) in a 1:800 and 1:150 dilution, respectively, in blocking buffer. Cells were washed 3 times with PBS, 15 min each wash and mounted using antifade solution with DAPI (P-36931, Life Technologies). To assess antibody specificity, controls with secondary antibody but lacking primary antibody against nucleolin were used with HEI-OC1 transfected with scramble RNA ([S1 Fig](#pone.0130827.s001){ref-type="supplementary-material"}).

Images of immunostained cells were acquired on a LSM 700 (Carl Zeiss) confocal microscope with a 40x/1.3 objective lens configured to detect DAPI-labeled nuclei using the 405 nm laser, phalloidin-labeled filamentous actin cytoskeleton using the 488 nm laser, and the 555 nm laser for nucleolin. Quantitative analysis of the micrographs was performed to compare the abundance of nucleolin in the nucleus of the different cell types and in response to treatment. For this, single-stain controls were used to determine the background levels of nucleolin signal. In total, 15 to 22 cells for each cell type and treatment in multiple fields of view were acquired using identical settings. Intensity threshold was then used to distinguish nuclear regions of high nucleolin abundance versus more diffuse ones. The total intensity in nucleolin-abundant regions normalized by the total nuclear area was then calculated. All data acquisition and measurements were performed using Zen Black software (Carl Zeiss).

Statistical Analysis {#sec015}
--------------------

For GWAS, the association study using allelic frequency test based on case vs. control was performed with PLINK. Only the SNPs within 20 kb of a gene were considered as reported in the human genome build 18 (NCBI36). The genome-wide significance threshold was set to 5 x 10^−7^ and threshold for suggestive association was set to 5 x 10^−4^. Because of the small sample size, we also calculated empirical significance levels, corrected for multiple hypothesis, using 30,000 permutations for each SNP using PLINK \[[@pone.0130827.ref019]\]. These empirical p-values were used to confirm genome-wide significance. Linkage disequilibrium plot was generated with SNAP \[[@pone.0130827.ref026]\] using chromosomal position of SNPs given by 1000 genomes \[[@pone.0130827.ref027]\].

The range of statistical power of the study was estimated with the 'twoStageGwasPower' package in R \[[@pone.0130827.ref028]\], which is an implementation of the method for power calculation previously described \[[@pone.0130827.ref029]\]. One stage was considered for the calculation with NIHL prevalence at 16% worldwide \[[@pone.0130827.ref002]\] and with prevalence ranging from 21% \[[@pone.0130827.ref030]\] to over 50% \[[@pone.0130827.ref031]\] in military environment.

For *in vitro* studies of nucleolin-labeled cellular experiments, Student's t-test was performed to assess the difference of viability and distribution of nuclear-bound nucleolin between sh-Scr HEI-OC1 and sh-Ncl HEI-OC1 clones. The difference was considered significant for p \< 0.05.

Results {#sec016}
=======

We analyzed the association between genotype and hearing threshold shift of 41 subjects randomly selected from a pool of 314 young males exposed to repeat 157 dB SPL impulse noise for 10 days. Principal component analysis showed stratification in the sampled population with 25% of subjects (n = 10) overlapping with the Mexican ancestry cluster (MEX) and 75% (n = 31) overlapping with the European ancestry cluster (CEU) of the HapMap population ([S2 Fig](#pone.0130827.s002){ref-type="supplementary-material"}). After all quality controls and adjustment for population stratification, 289,036 genotyped SNPs and 41 genotyped samples of the 48 initially selected for the study remained for analysis. This consisted of 19 subjects experiencing hearing threshold shift and 22 subjects with no hearing loss. For the no hearing loss group, the mean threshold shift was -0.4 dB HL and for the hearing loss group, the mean threshold shift was 2.2 dB HL, showing a mean difference of 2.6 dB HL per frequency at 2, 3 and 4 kHz per ear between the two groups (p \< 0.001, Student's t-test). At the individual level, this mean threshold shift represents a difference of 15.6 dB HL per subject between the two groups. A unified representation of hearing changes using composite audiogram data shows that subjects within both groups responded differently to noise exposure ([Fig 1](#pone.0130827.g001){ref-type="fig"}). In the hearing loss group, subjects performed worse on the audiological test after noise exposure for either of the better or worse ear, consistent with a difference at conversational frequencies. In contrast, subjects experiencing no hearing loss performed similarly on their audiological test before and after noise exposure for either the better or worse ear.

![Composite audiograms of the hearing threshold pre- and post-noise exposure.\
Pre-noise exposure audiograms (circle, full line) and post-noise exposure audiograms (cross, dashed line) are shown for (A) the better ear of subjects without hearing loss; (B) the better ear of subjects with hearing loss; (C) the worse ear of subjects without hearing loss and (D) the worse ear of subjects with hearing loss. Data are the mean dB HL ± s.e.m at frequencies 2, 3 and 4 kHz.](pone.0130827.g001){#pone.0130827.g001}

Genome-Wide Significant SNP Found in Nucleolin Gene {#sec017}
---------------------------------------------------

We identified SNP rs7598759 associated at genome-wide significance (p \< 5 x 10^−7^ and p = 0.01 after permutation and correction; Odds Ratio = 12.75) ([Fig 2](#pone.0130827.g002){ref-type="fig"}). This SNP is located in intron 9 of the nucleolin gene on chromosome 2q37.1 and contributes to a gain/loss of a CpG site. Additionally, two other SNPs, rs4973409 and rs4973410, located within the 20 kb flanking region of nucleolin, and one SNP, rs7571691, located in the gene *NMUR1* (neuromedin U receptor 1) contiguous to nucleolin were in suggestive association (p \< 5 x 10^−4^). Linkage disequilibrium map showed genome-wide significant SNP rs7598759 is in strong linkage disequilibrium with the non-genotyped SNP rs6754426 ([Fig 3](#pone.0130827.g003){ref-type="fig"}) and the three SNPs in suggestive association ([S1 Table](#pone.0130827.s003){ref-type="supplementary-material"}).

![Manhattan plot of the SNPs associated with NIHL.\
Genome-wide significant SNP rs7598759 is located within nucleolin gene on chromosome 2 (black arrow). The-log10 of the p-value (y-axis) for each of the analyzed SNPs is shown with respect to their genomic location (x-axis) with chromosomes in alternate colors. Dashed lines indicate thresholds for genome-wide association (p \< 5 x 10^−7^, red) and suggestive association (p \< 5 x 10^−4^, blue).](pone.0130827.g002){#pone.0130827.g002}

![Regional linkage disequilibrium of newly identified SNP associated with NIHL.\
The location of genome-wide significant SNP, rs7598759 (top large filled diamond), is shown respective to the location of genes (green arrow and arrowhead, length based on size) within a 500 kb fragment of chromosome 2 (2q37.1). Genotyped SNP rs7598759 located within nucleolin gene (NCL) is in strong linkage disequilibrium (r^2^ \> 0.9) with non-genotyped SNP rs6754426 (black arrow). Linkage disequilibrium (r^2^) is based on Hapmap CEU population with decreasing intensity of colored diamonds indicating decreasing linkage disequilibrium with SNP rs7598759. A SNP was considered in strong LD for r^2^ \> 0.8 (black dashed line). The plot was generated with SNAP \[[@pone.0130827.ref026]\] using 1000 genomes \[[@pone.0130827.ref027]\] for the chromosomal position of SNPs.](pone.0130827.g003){#pone.0130827.g003}

Additional SNPs of Interest {#sec018}
---------------------------

We identified 7 SNPs with suggestive evidence of association (p \< 5 x 10^−4^) located in or within 20 kb of 7 genes with links to hearing loss ([Table 1](#pone.0130827.t001){ref-type="table"}). We also identified another 43 SNPs with suggestive significance in or within 20 kb of 36 genes where no relation to hearing loss had been previously reported ([Table 2](#pone.0130827.t002){ref-type="table"}). Of the 7 SNPs found in genes linked to hearing loss, three are of particular interest: two SNPs, rs7429015 and rs2436106, are found in genes coding for potassium channels which are important regulators of known pathways affected in hearing loss, and a third SNP, rs4374858, is found in gene encoding a membrane receptor protein. Of these, SNP rs7429015 is located in the intron of gene *KCNMB2* that encodes the potassium large conductance calcium-activated channel subunit β2; SNP rs2436106 is located within gene *KCNQ3* which is part of a family potassium voltage-gated channel protein associated with NIHL \[[@pone.0130827.ref032]\], \[[@pone.0130827.ref033]\]; and SNP rs4374858 is located within 20 kb of gene *GPR6*, which encodes a G protein-coupled receptor.

10.1371/journal.pone.0130827.t001

###### Location of the SNPs with suggestive association with noise-induced hearing loss in genes previously related to hearing loss.

![](pone.0130827.t001){#pone.0130827.t001g}

  Chromosome   Gene        SNP[^(a)^](#t001fn001){ref-type="table-fn"}   Position[^(b)^](#t001fn002){ref-type="table-fn"}   Minor/Major Allele   P-value     OR
  ------------ ----------- --------------------------------------------- -------------------------------------------------- -------------------- ----------- --------
  3            KCNMB2      rs7429015                                     179856818                                          A/G                  5.00E-004   5.213
  6            GPR6        rs4374858                                     110402134                                          G/C                  3.95E-004   0.1901
  8            KCNQ3       rs2436106                                     133191476                                          T/C                  5.00E-004   5.213
  8            RAB11FIP1   rs4956542                                     37877696                                           T/C                  1.27E-004   22.36
  10           PLAU        rs2227578                                     75348721                                           T/C                  3.95E-004   0.1901
  12           LGR5        rs10784926                                    70239349                                           C/T                  3.61E-004   6.333
  14           SLC39A9     rs7147710                                     68975478                                           T/C                  2.11E-004   5.829

^**(a)**^SNPs are located in or within 20 kb of the listed gene.

^**(b)**^Position on chromosome based on NCBI build 36. OR--Odds ratio of the association.

10.1371/journal.pone.0130827.t002

###### Location of the SNPs with suggestive association with noise-induced hearing loss in genes that have not been previously associated with hearing loss.

![](pone.0130827.t002){#pone.0130827.t002g}

  Chromosome   Gene       SNP[^(a)^](#t002fn001){ref-type="table-fn"}   Position[^(b)^](#t002fn002){ref-type="table-fn"}   Minor/Major Allele   P-value     OR
  ------------ ---------- --------------------------------------------- -------------------------------------------------- -------------------- ----------- ---------
  1            AGBL4      rs319981                                      48924473                                           G/A                  1.32E-004   0.1605
  1            CAMTA1     rs4908425                                     6823605                                            A/G                  9.58E-005   9
  1            FNDC7      rs11102337                                    109091734                                          C/G                  4.74E-004   5.128
  1            MR1        rs3845422                                     179279594                                          A/G                  3.23E-004   0.1128
  1            STXBP3     rs11102337                                    109091734                                          C/G                  4.74E-004   5.128
  2            C2orf52    rs7571691                                     232077645                                          C/T                  1.32E-004   0.1605
  2            C2orf52    rs6754952                                     232089489                                          T/G                  2.89E-004   0.1773
  2            LTBP1      rs4670387                                     33361950                                           T/A                  4.18E-004   5.873
  2            LTBP1      rs11124313                                    33366087                                           A/C                  4.18E-004   5.873
  2            NMUR1      rs7571691                                     232077645                                          C/T                  1.32E-004   0.1605
  2            NMUR1      rs1667305                                     232112073                                          A/G                  1.56E-004   0.1667
  2            NMUR1      rs1667313                                     232116262                                          A/C                  1.56E-004   0.1667
  2            NMUR1      rs6754952                                     232089489                                          T/G                  2.89E-004   0.1773
  3            NCBP2      rs746037                                      198160884                                          G/A                  4.18E-004   5.873
  3            PIGZ       rs746037                                      198160884                                          G/A                  4.18E-004   5.873
  3            SENP5      rs746037                                      198160884                                          G/A                  4.18E-004   5.873
  4            ELOVL6     rs7669237                                     111240190                                          G/A                  1.27E-004   22.36
  4            ELOVL6     rs10032613                                    111241207                                          A/T                  1.27E-004   22.36
  4            ODZ3       rs6839881                                     183966131                                          T/A                  1.27E-004   22.36
  5            ARHGAP26   rs4912893                                     142407999                                          T/C                  4.89E-004   5.347
  6            LCA5       rs9294147                                     80248251                                           C/T                  2.33E-004   12.25
  6            SYNE1      rs4645434                                     152706954                                          G/T                  4.61E-004   5.559
  6            SYNE1      rs9397102                                     152717547                                          T/C                  4.61E-004   5.559
  6            SYNE1      rs7747005                                     152705880                                          A/G                  4.89E-004   5.347
  7            MAGI2      rs11973067                                    78374514                                           C/T                  4.95E-004   5.143
  7            WDR60      rs6459913                                     158408025                                          G/A                  3.38E-004   0.05225
  9            PIP5K1B    rs1333340                                     70516547                                           G/C                  4.89E-004   0.1846
  9            PIP5K1B    rs4744685                                     70520218                                           G/A                  4.89E-004   0.1846
  9            PIP5K1B    rs2184117                                     70520904                                           T/G                  4.89E-004   0.1846
  9            SUSD1      rs10817281                                    113988347                                          G/C                  4.74E-004   5.128
  9            ZNF169     rs10993121                                    96063849                                           T/C                  1.33E-004   0.1425
  10           C10orf55   rs2227578                                     75348721                                           T/C                  3.95E-004   0.1901
  11           NELL1      rs4471417                                     21386046                                           G/C                  4.00E-004   0.1515
  12           CPNE8      rs10506125                                    37406554                                           C/T                  2.89E-004   0.1773
  14           CLEC14A    rs1028930                                     37781365                                           T/C                  2.96E-004   7.02
  14           ERH        rs897330                                      68906063                                           G/T                  2.11E-004   5.829
  14           GALNTL1    rs897330                                      68906063                                           G/T                  2.11E-004   5.829
  14           GALNTL1    rs12884348                                    68895853                                           T/C                  5.00E-004   5.213
  14           JDP2       rs3784013                                     75000823                                           G/T                  3.67E-004   8.913
  16           A2BP1      rs7196635                                     7693602                                            T/C                  5.00E-004   5.213
  16           FTO        rs7205213                                     52434067                                           T/C                  4.40E-004   5.167
  16           FTO        rs8053367                                     52432985                                           A/C                  4.95E-004   5.143
  16           FTO        rs8053740                                     52433213                                           G/C                  4.95E-004   5.143
  16           FTO        rs7203051                                     52433650                                           G/C                  4.95E-004   5.143
  16           FTO        rs7205009                                     52433945                                           T/C                  4.95E-004   5.143
  17           COX10      rs2159132                                     13946164                                           C/T                  4.74E-004   5.128
  19           FUT3       rs778809                                      5781302                                            A/G                  4.61E-004   5.559
  19           FUT3       rs17271883                                    5785212                                            A/G                  4.61E-004   5.559
  19           FUT6       rs778809                                      5781302                                            A/G                  4.61E-004   5.559
  19           FUT6       rs17271883                                    5785212                                            A/G                  4.61E-004   5.559
  19           NRTN       rs778809                                      5781302                                            A/G                  4.61E-004   5.559
  19           NRTN       rs17271883                                    5785212                                            A/G                  4.61E-004   5.559
  20           CRLS1      rs6053819                                     5930604                                            G/A                  2.08E-004   5.963
  20           MCM8       rs6053819                                     5930604                                            G/A                  2.08E-004   5.963

^**(a)**^SNPs are located in or within 20 kb of the listed gene.

^**(b)**^Position on chromosome based on NCBI build 36. OR--Odds ratio of the association.

Nucleolin Down-Regulation Increases Susceptibility to Oxidative Stress in Cochlear Cell Model {#sec019}
---------------------------------------------------------------------------------------------

The present GWAS results reveal significant association of SNP rs7598759 within the nucleolin gene that encodes a multifunctional protein shown to be expressed in numerous cell types, including primary cochlear cell cultures of rats \[[@pone.0130827.ref034]\]. Given that nucleolin also interacts with proteins associated with various forms of hearing loss, including NIHL, its dysregulation in NIHL susceptibility is plausible. We therefore tested the effect of nucleolin on the viability of cochlear cells *in vitro*.

To test the potential effect of nucleolin dysregulation on hearing-loss, we utilized HEI-OC1 cochlear cell line commonly used as a model for drug-induced ototoxicity \[[@pone.0130827.ref035]\], \[[@pone.0130827.ref036]\]. These cells contain a temperature-sensitive mutant of SV40 large-T antigen allowing the cells to grow at permissive temperature (33°C) and differentiate at non-permissive temperature (39°C). Under cisplatin exposure, a chemotherapeutic drug responsible of hearing loss in 60% of pediatric patients \[[@pone.0130827.ref037]\], HEI-OC1 cells exhibit alterations of biomolecular pathways also known to be affected in NIHL \[[@pone.0130827.ref035]\], \[[@pone.0130827.ref036]\] and can be used as a surrogate for *in vitro* NIHL studies.

We constructed stable clones expressing shRNA targeted against nucleolin (sh-Ncl). In comparison to shRNA scramble control clones (sh-Scr), nucleolin expression in silenced sh-Ncl clones was significantly reduced ([Fig 4A](#pone.0130827.g004){ref-type="fig"}). The down-regulation of nucleolin in sh-Ncl clones significantly increased cellular toxicity in either untreated cells (p \< 0.001, Student's t-test) or under cisplatin-induced stress (p \< 0.001, Student's t-test) when compared to control cells ([Fig 4B](#pone.0130827.g004){ref-type="fig"}). This increase in sensitivity in cells expressing lower nucleolin was also reflected on the nuclear distribution of nucleolin as revealed by confocal microscopy. Expression of nucleolin in sh-Scr control clones was associated with the fibrillar components of the nucleus ([Fig 4C](#pone.0130827.g004){ref-type="fig"}), similar to previous reports in normal cells \[[@pone.0130827.ref038]\]. Down-regulation of nucleolin in sh-Ncl clones reduced the number of nucleoli-associated nucleolin (p \< 0.001, Student's t-test) ([Fig 4D](#pone.0130827.g004){ref-type="fig"}). Nuclear redistribution of nucleolin was also altered in sh-Scr control clones exposed to 20 μM of cisplatin for 6 h ([Fig 4E](#pone.0130827.g004){ref-type="fig"}) similar to that previously reported in the nucleus of mouse fibroblasts \[[@pone.0130827.ref039]\]. This redistribution was further altered in sh-Ncl clones with a further significant loss of nucleoli-associated nucleolin (p \< 0.05, Student\'s t-test) ([Fig 4F](#pone.0130827.g004){ref-type="fig"}).

![Down-regulation of nucleolin affects viability and nuclear redistribution in HEI-OC1 cells.\
(A) Western blots of two independent experimental replicates show HEI-OC1 wild type cells and transfected HEI-OC1 cells with either shRNA targeted against nucleolin (sh-Ncl) or with scramble shRNA control (sh-Scr). (B) Cytotoxicity of sh-Scr and sh-Ncl cells either untreateds or incubated 6 h with Cisplatin at 20 μM from duplicate experiments with n = 4. (C, D) Redistribution of nucleolin in shRNA-transformed HEI-OC1 cells. Transfected HEI-OC1 cells with shRNA targeted against nucleolin (sh-Ncl) or with scramble shRNA as control (sh-Scr) were untreated or (E, F) incubated with 20 μM Cisplatin for 6 h. Cells were stained with anti-nucleolin antibody decorated with secondary goat anti-rabbit IgG Texas-Red conjugate and counterstained with DAPIand phalloidin. Images were then merged to form color composite images. The images are representative of the results of each cell type and treatment. White scale bar represents 20 μm. The change in the total nucleolin intensity was normalized to nuclear area in untreated cells (D) or in cells incubated 6 h with cisplatin at 20μM (F). Statistical significance was assessed with Student\'s t-test (\*\*\*p \< 0.001, \*p \< 0.05). Experiments were performed in non-permissive conditions.](pone.0130827.g004){#pone.0130827.g004}

Discussion {#sec020}
==========

Previous susceptibility studies have identified NIHL associated genes mainly in pathways that regulate oxidative stress response and potassium channels. Our results show that novel candidate genes in these pathways are associated with NIHL. In particular, the results reported here suggest that nucleolin, a multifunctional phosphoprotein involved in the modulation of cell proliferation and protection against apoptosis \[[@pone.0130827.ref040], [@pone.0130827.ref041]\], is a strong candidate for NIHL susceptibility. This is supported by the numerous interactions nucleolin has with hearing loss-associated proteins, such as heat shock protein HSP70 \[[@pone.0130827.ref042], [@pone.0130827.ref043]\], pro-apoptotic protein P53 \[[@pone.0130827.ref044], [@pone.0130827.ref045]\] and mitochondrial-associated apoptosis protein Bcl2 \[[@pone.0130827.ref046]\]. The nature of the associations of these proteins with NIHL is varied and intervenes at several levels of regulation of gene expression and protein activity. For example, polymorphisms in the gene coding for HSP70 alone or in combination with genes coding for other heat shock proteins, are associated with NIHL susceptibility \[[@pone.0130827.ref014], [@pone.0130827.ref047]\] and sudden sensorineural hearing loss \[[@pone.0130827.ref048]\]. It has also been shown experimentally that under various cell stresses, nucleolin regulates P53 \[[@pone.0130827.ref045], [@pone.0130827.ref049]\], a pro-apoptotic protein that is found activated in outer hair cells and Hensen\'s cells shortly after impulse noise exposure \[[@pone.0130827.ref012]\]. Finally, over-expression of Hsp70 \[[@pone.0130827.ref050]\] and Bcl2 \[[@pone.0130827.ref051], [@pone.0130827.ref052]\] or inhibition of P53 \[[@pone.0130827.ref052]\] in rodents reduces aminoglycoside-induced ototoxicity.

All of these NIHL associated proteins, together with nucleolin, contribute to the apoptotic cellular response induced by oxidative stress and DNA damage, which are known to result in permanent hearing loss \[[@pone.0130827.ref005], [@pone.0130827.ref008]\]. The prevention of apoptosis in numerous human-derived cell lines under various stress conditions follows from an increased expression of nucleolin \[[@pone.0130827.ref053], [@pone.0130827.ref054]\] and appears to be mediated by interactions with NIHL-associated proteins Bcl2, HSPA1A (Heat Shock 70 Protein 1A) and p53. These interactions are essential in the regulation of these proteins, in particular under oxidative stress. For instance, results indicate that nucleolin exerts a regulatory control of HSPA1A \[[@pone.0130827.ref043]\] and that either its over-expression or increased stability by over-expression of HSPA1A in H~2~O~2~-exposed rat cardiomyocytes prevents apoptosis \[[@pone.0130827.ref042], [@pone.0130827.ref055]\]. It has also been shown that the interaction of nucleolin with RPL26 (ribosomal protein L26), a necessary protein for induction of P53 translation following DNA damage \[[@pone.0130827.ref045]\], prevents the translation of P53 and P53-dependent apoptosis \[[@pone.0130827.ref045], [@pone.0130827.ref049]\].

In the HEI-OC1 cochlear cell model, our *in vitro* results show that down-regulation of nucleolin decreased cell viability and support the role of nucleolin in the regulation of cell death of cochlear sensory cells. The effect of nucleolin down-regulation is actually consistent with reports in other cell models. Taken together, our GWAS data and *in vitro* studies reported herein suggest that nucleolin might be a potential target for therapeutic intervention in context with NIHL. No previous study has investigated the role of nucleolin in hearing loss, although other studies have shown that nucleolin dysregulation, together with the proteins it interacts with, Bcl2, P53 and HSP70, have been associated in a wide range of cancers, viral infections and autoimmune diseases \[[@pone.0130827.ref041]\].

The potassium recycling pathways that maintain the electrochemical gradient across cell compartments and mediate potassium currents in the cochlea are also essential for hearing. Consequently, mutations and polymorphisms in several genes involved in these pathways lead to or have been associated with hearing loss \[[@pone.0130827.ref015], [@pone.0130827.ref056]\]. These include potassium-gated voltage channel genes *KCNE1*, *KCNQ1* and *KCNQ4* \[[@pone.0130827.ref032], [@pone.0130827.ref033]\], potassium large-conductance calcium-activated channel subunit *KCNMA1* \[[@pone.0130827.ref057]\] and potassium inwardly-rectifying channel *KCNJ10* \[[@pone.0130827.ref033]\].

In this study, we identified two additional candidate potassium channels genes *KCNQ3* and *KCNMB2* associated with hearing threshold shift. Although *KCNQ3* has not been previously reported in association with hearing loss, family members of this gene, including *KCNQ1* and *KCNQ4*, have been reported associated with NIHL \[[@pone.0130827.ref032]\], \[[@pone.0130827.ref033]\] which supports the possible role of *KCNQ3*. Changes in *KCNQ3* activation alone have been linked with induction of tinnitus \[[@pone.0130827.ref058]\], while the dimerization of KCNQ3 with other potassium channels seems to be essential for hearing. For example, dimers of KCNQ3/4 modulate the dynamics of activation of hearing loss-associated candidate *KCNQ4* \[[@pone.0130827.ref059]\] and might contribute to the critical low-voltage activated potassium conductance in both inner and outer hair cells of mice \[[@pone.0130827.ref060]\]. In addition, another dimer, KCNQ2/3, has been shown to regulate apoptosis in cortical and hippocampal neurons \[[@pone.0130827.ref061]\].

Another candidate gene, *KCNMB2*, is a subunit of large-conductance calcium-activated potassium channels previously reported in linkage disequilibrium with rs4603971, another SNP in suggestive association with hearing loss \[[@pone.0130827.ref062]\]. In addition, KCNMB2 subunit interacts with KCNMA1 \[[@pone.0130827.ref063]\], the α-subunit of potassium large conductance calcium-activated channel which also presents NIHL-associated polymorphisms \[[@pone.0130827.ref057]\] and whose deletion produces progressive deafness \[[@pone.0130827.ref063]\]. Furthermore, both protein subunits are under regulation of interferon-γ \[[@pone.0130827.ref064]\], an inflammatory marker up regulated in cases of sensorineural hearing loss \[[@pone.0130827.ref065]\]. Our results independently confirm the potential role of *KCNMB2* for hearing loss susceptibility. Of interest, both candidate genes *KCNQ3* and *KCNMB2* as well as *KCNJ10* previously mentioned, appear to be associated with epilepsy \[[@pone.0130827.ref059], [@pone.0130827.ref066], [@pone.0130827.ref067]\], although only *KCNJ10* has been thus far associated with both epilepsy and hearing loss \[[@pone.0130827.ref033]\].

The third SNP, rs4374858, is located within 20 kb of gene *GPR6* and encodes a G protein-coupled receptor. Interestingly, this receptor shows a high affinity for sphingosine-1-phosphate \[[@pone.0130827.ref068]\], a sphingolipid metabolite that protects the cochlea against ototoxicity induced by gentamicin, an antibiotic member of aminoglycoside family \[[@pone.0130827.ref069]\].

Many of the SNPs identified in this study, including genome-wide significant SNP rs7598759 in nucleolin, are located within introns. The means by which these polymorphisms might contribute to altering the pathways in which the associated proteins are involved is unknown, although we can speculate that they could affect gene transcript levels, as previously reported \[[@pone.0130827.ref070]\]. This might occur through various regulatory mechanisms involving different classes of non-coding RNA, for example \[[@pone.0130827.ref071]\]. Considering also that the nucleolin SNP identified in this report contributes to a Gain/Loss of a CpG site, one such possible mechanism may involve changes in DNA methylation and epigenetic controls. Such changes may be under the constraint of environmental factors, which are actually known to significantly affect DNA methylation \[[@pone.0130827.ref072], [@pone.0130827.ref073]\] and we would anticipate noise exposure to be another form of environmental stress. Epigenetic control from environmental noise might be a strong component of the cochlear cell response and therefore sites with SNPs variants that alter DNA methylation might play a role in susceptibility to noise.

Does nucleolin dysregulation confer a predictive outcome for permanent threshold shift in humans? In practice, recovery from temporary threshold shift in human subjects varies from minutes to days. For example, human ears show significant recovery within hours from a 4-hour noise exposure at 100 dBA and full recovery within one week \[[@pone.0130827.ref074]\]. In more extreme cases in animals with severe noise exposures that generate up to 40 dB threshold shift at 24h, full recovery is observed within 2 weeks \[[@pone.0130827.ref075]\]. Based on the kinetics of recovery, we assume that the hearing loss experienced by some subjects at the post-exposure audiogram collected for the study would be permanent, which falls within the range of reported hearing loss for this population.

Many of the SNPs identified in this study are in genes that can potentially modulate apoptotic pathways and contribute to either temporary or permanent hearing loss. Indeed, although the loss of hair cells following activation of apoptotic signals clearly contributes to permanent hearing loss, it is not yet clear whether transient activation of these same pathways will contribute to temporary hearing loss \[[@pone.0130827.ref012]\]. Until further studies clarify this point, we suggest the apoptosis-related genes reported in this study contribute to either temporary or permanent NIHL.

In the placebo arm of the overall Marine recruit study, 35% of subjects experienced a threshold shift when exposed to occupational noise, which is well above the anticipated 16% from noise exposure studies conducted in other occupational settings worldwide \[[@pone.0130827.ref002]\]. Looking beyond the NIHL susceptibility polymorphisms identified in our study, we speculate that the environment training regimen undertaken by the subjects contributed to increased hearing loss and was likely mediated by physiological stress, inflammation, and oxidative stress \[[@pone.0130827.ref003], [@pone.0130827.ref006], [@pone.0130827.ref014]\].

We posit that strong environmental conditions, leading to exercise-induced inflammation and fatigue, contribute to NIHL susceptibility under certain occupational conditions. In this context, the state of inflammation and fatigue of an individual becomes a relevant risk factor of noise exposure in the work environment. Physiologic measures of stress, inflammation and oxidative stress were not evaluated in this study. However they are important factors to be explored in further studies to help place noise exposure in context with the genetic susceptibility to NIHL.

Intensive exercise or prolonged sleep restriction periods similar to Marine recruits training might result in altered hearing threshold shifts. Several reports have shown a significant increase in expression of inflammation markers C-reactive and IL-6 proteins \[[@pone.0130827.ref076], [@pone.0130827.ref077]\] under less extreme conditions than experienced by these Marine recruits. Reduction of exercise performance and fatigue resistance also correlates with an increase in IL-6 expression when ATP-activated protein kinase (AMPK) that senses cellular energy homeostasis to maintain ATP levels is altered \[[@pone.0130827.ref078]\]. It is therefore possible that the subjects in the study presented systemic levels of inflammation above baseline.

There is also growing evidence that hearing loss is a risk factor in inflammation-driven diseases such as diabetes \[[@pone.0130827.ref079]\] and dementia \[[@pone.0130827.ref080], [@pone.0130827.ref081], [@pone.0130827.ref082], [@pone.0130827.ref083]\] and that inflammation itself contributes to hearing loss. Data show that expression of inflammatory cytokines IL-1b and IL-6 in the inner ear increases shortly after noise exposure \[[@pone.0130827.ref084], [@pone.0130827.ref085]\] and that long-term inflammation measured by C-reactive protein correlates with hearing loss \[[@pone.0130827.ref086]\]. In addition, other reports suggest that inflammation levels correlate with the capability to recover from hearing loss injuries \[[@pone.0130827.ref087]\] and that blocking IL-6 signaling to suppress inner ear inflammation reduces NIHL \[[@pone.0130827.ref085]\].

To address the question of whether different sets of genes will have an effect on the susceptibility to either impulse or continuous noise, we compared the SNPs genotyped in our study to previously reported SNPs associated with NIHL. Of the 46 SNPs within 23 candidate genes previously reported associated with NIHL ([Table 3](#pone.0130827.t003){ref-type="table"}), 15 SNPs were genotyped in our dataset. Of these 15 SNPs, the most significant SNP was found in gene *WSF1* (p \< 7 x 10^−4^) identified in another impulse noise study \[[@pone.0130827.ref088]\]. In contrast, SNPs identified in continuous noise studies, such as in catalase and ITGA8 genes did not show association (p \> 0.7). This result may suggest that different sets of candidate polymorphisms are specifically associated with either impulse or continuous noise exposure leading to hearing loss. Although impulse noise was the main component of this study of noise exposure, we cannot fully rule out the possibility of continuous noise exposure during the course of the study.

10.1371/journal.pone.0130827.t003

###### List of published candidate genes with SNPs associated with NIHL.

![](pone.0130827.t003){#pone.0130827.t003g}

  Gene Symbol   Gene Name                                                               References
  ------------- ----------------------------------------------------------------------- ------------------------------------------------------------------------------------
  CAT           Catalase                                                                \[[@pone.0130827.ref089]\]
  GJB1          Gap junction, beta 1                                                    \[[@pone.0130827.ref033]\]
  GJB2          Gap junction, beta 2                                                    \[[@pone.0130827.ref033]\]
  GJB4          Gap junction, beta 4                                                    \[[@pone.0130827.ref033]\]
  GRHL2         Grainyhead-like 2                                                       \[[@pone.0130827.ref033]\]
  GSTM1         Glutathione S-transferase mu 1                                          \[[@pone.0130827.ref090]\], \[[@pone.0130827.ref091]\]
  GSTP1         Glutathione S-transferase pi 1                                          \[[@pone.0130827.ref090]\]
  GSTT1         Glutathione S-transferase theta 1                                       \[[@pone.0130827.ref090]\], \[[@pone.0130827.ref091]\]
  HSPA1A        Heat shock 70kDa protein 1A                                             \[[@pone.0130827.ref047]\], \[[@pone.0130827.ref092]\], \[[@pone.0130827.ref093]\]
  HSPA1B        Heat shock 70kDa protein 1A                                             \[[@pone.0130827.ref047]\], \[[@pone.0130827.ref092]\], \[[@pone.0130827.ref093]\]
  HSPA1L        Heat shock 70kDa protein 1-like                                         \[[@pone.0130827.ref047]\], \[[@pone.0130827.ref092]\], \[[@pone.0130827.ref093]\]
  ITGA8         Integrin alpha 8                                                        \[[@pone.0130827.ref033]\]
  KCNE1         Potassium voltage-gated channel, member 1                               \[[@pone.0130827.ref032]\], \[[@pone.0130827.ref033]\]
  KCNJ10        Potassium inwardly-rectifying channel, subfamily J, member 10           \[[@pone.0130827.ref033]\]
  KCNMA1        Potassium large conductance calcium-activated channel, alpha member 1   \[[@pone.0130827.ref033]\]
  KCNQ1         Potassium voltage-gated channel, KQT-like subfamily, member 1           \[[@pone.0130827.ref032]\], \[[@pone.0130827.ref033]\]
  KCNQ4         Potassium voltage-gated channel, KQT-like subfamily, member 4           \[[@pone.0130827.ref032]\], \[[@pone.0130827.ref033]\]
  MYH14         Myosin, heavy chain 14, non-muscle                                      \[[@pone.0130827.ref033]\]
  PCDH15        Protocadherin 15                                                        \[[@pone.0130827.ref033]\]
  PON2          Paraoxonase 2                                                           \[[@pone.0130827.ref094]\]
  POU4F3        POU domain, class 4, transcription factor 3                             \[[@pone.0130827.ref033]\]
  SOD2          Superoxide dismutase 2                                                  \[[@pone.0130827.ref094]\], \[[@pone.0130827.ref095]\]
  WFS1          Wolfram syndrome 1                                                      \[[@pone.0130827.ref088]\]

Although the small sample size is a limiting factor, many of the results shown here converge with previously reported data and add more weight to previously identified polymorphisms associated with NIHL. Estimation of the power of this study, which depends on the NIHL prevalence and genetic model selected, is highly variable (0.02 \< *β* \< 0.63), challenging its objective interpretation. However, the results of *in vitro* experiments confirm the main finding of this study supporting the potential role of nucleolin in NIHL susceptibility.

Conclusion {#sec021}
==========

We conducted the discovery phase of a GWAS in subjects undergoing first encounter with occupational impulse noise and identified nucleolin as a new candidate gene associated with NIHL susceptibility. This study is the first to suggest the role of nucleolin in NIHL. We have further identified 7 genes with suggestive association that are known to be involved in hearing-loss pathways and 36 additional genes that have not previously been directly related to hearing-loss pathways. Further studies are needed to confirm the relevance of these polymorphisms to NIHL. Nucleolin was tested in a cochlear cell model and reveals susceptibility to ototoxic stress. Taken together, our GWAS data and *in vitro* studies reported herein suggest that nucleolin is a potential candidate associated with NIHL in this population.

Supporting Information {#sec022}
======================

###### Antisera specificity control for nucleolin antibody decoration in HEI-OC1 cells.

Cultured HEI-OC1 cells with scramble shRNA control immuno-decorated with (B) goat anti-rabbit IgG Texas-Red conjugate used as antibody specific control. Cells were further counterstained with (A) DAPI to show nuclear profile and (C) phalloidin Alexa 488 conjugate to show actin cytoskeletal features. (D) The merge panel clearly shows nuclear and actin profiles and absence of non-specific staining. White scale bar represents 20 μm.

(TIF)

###### 

Click here for additional data file.

###### Principal component analysis of the sampled population.

This figure demonstrates the results of the principal component analysis to identify stratification in order to avoid bias. Eleven sub-populations from 1000 Genomes were tested to stratify the NIHL study population. Principal component 1, defined as axis of the linear least square fit of the tested population and principal component 2, which is defined as second axis of the linear least square fit orthogonal to principal component 1, show the largest genetic variance between ASW (African ancestry in Southwest USA), CEU (Utah residents with Northern and Western European ancestry), CHB (Han Chinese in Beijing, China), CHD (Chinese in Metropolitan Denver), GIH (Gujarati Indians in Houston), JPT (Japanese in Tokyo), LWK (Luhya in Webuye, Kenya), MEX (Mexican ancestry in Los Angeles), MKK (Maasai in Kinyawa, Kenya), TSI (Toscans in Italy), YRI (Yoruba in Ibadan).

(TIF)

###### 

Click here for additional data file.

###### Linkage disequilibrium between genome-wide SNP and suggestive SNPs in the nucleolin locus.

Genome-wide significant (peak) SNP rs7598759 is in strong linkage disequilibrium (LD) with the three suggestive SNPs (D\' \> 0.9) although some the correlation are low due to lower allele frequency (r^2^ \< 0.8). Linkage disequilibrium and distances between pairs of SNPs were calculated from either the 1000 Genomes \[[@pone.0130827.ref027]\] or HapMap release 22 \[[@pone.0130827.ref022]\] based on the CEU population.

(XLSX)

###### 

Click here for additional data file.
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